Live starting prices

GoodRx Care vs Hers: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher & Publisher
Reviewed & updated · Cites primary sources (FDA, NEJM, CMS) · Not medical advice
54 providers verified independently·Independent researchHow we rank →

Short answer: Hers scores higher on our rubric, 7.3/10 against 6.2/10. Full reasoning, pricing and the cases where the other one wins are below.

Hers beats GoodRx Care overall, scoring 7.3/10 vs 6.2/10. Published pricing is not a like-for-like monthly comparison: GoodRx Care is $119/mo subscription + medication; Hers is $188 first month, then $298/mo. Choose GoodRx Care for users who want fda-approved brand-name glp-1 access at market-leading subscription pricing, $199/mo wegovy intro, $349/mo standard, plus oral wegovy pill. Choose Hers for women who want a female-focused platform and can budget at least $188 initially and $298/mo ongoing for a $149 medication path.

A side-by-side look at GoodRx Care and Hers to help you decide. We compare them on:

  • Starting price per month
  • Our overall score, out of 10
  • Medication type, brand-name or compounded
  • Whether they accept insurance
  • Who each one is best for

GoodRx Care

#44 of 54
6.2/10

GoodRx Care was restructured in late 2025 from a pay-per-visit model into a telemedicine subscription: $39/mo intro rate (through January 2026) → $119/mo standard. Medication is priced aggressively: Ozempic/Wegovy $199/mo intro for the first 2 fills, then $349/mo standard. Oral Wegovy pill available at $149-199/mo.

Visit GoodRx Care
Higher Rated

Hers

#30 of 54
7.3/10

The women's health arm of Hims & Hers Health (NYSE: HIMS). Hers lists Wegovy pill, Foundayo, and Ozempic pill medication from $149, a Wegovy pen from $199, Zepbound from $299, and compounded options. A required Weight Loss Membership adds $39 in month one and $149/mo thereafter, so the all-in floor for a $149 medication path is $188 initially and $298/mo ongoing; exact product and dose prices vary.

Visit Hers
FeatureGoodRx CareHers
Why each oneThe only GLP-1 prescribing service integrated with the largest prescription discount platform in the US, automatically finding the cheapest pharmacy price for your medication.A major women-focused telehealth platform with a direct Novo Nordisk partnership (Wegovy pill from $149 and pen from $199 before required membership) and a Lilly partnership (Zepbound medication from $299) alongside compounded options.
Our Score6.2/107.3/10
Headline Price$119/mo subscription + medication$188 first month, then $298/mo
Medication TypeBrandBoth
Insurance AcceptedYesNo
Best ForUsers who want FDA-approved brand-name GLP-1 access at market-leading subscription pricing, $199/mo Wegovy intro, $349/mo standard, plus oral Wegovy pillWomen who want a female-focused platform and can budget at least $188 initially and $298/mo ongoing for a $149 medication path
Watch out forModel changed from pay-per-visit to subscription, users expecting à-la-carte pricing should double-check current termsPending federal enforcement action against the parent company. On July 29, 2026 the FTC, joined by Utah and California acting through Los Angeles County Counsel, filed a complaint against Hims & Hers Health, Inc. in the U.S. District Court for the Northern District of California, alleging violations of the FTC Act and the Restore Online Shoppers' Confidence Act over subscription billing, cancellation friction, and sharing consumer health information with advertising platforms. Case status is Pending. These are allegations, not findings.
Ranking#44#30
Get startedVisit GoodRx CareVisit Hers

Pros & Cons Compared

GoodRx Care

Pros

  • +2026 subscription rewrite, $119/mo standard membership with medication priced among the lowest on the market
  • +Wegovy/Ozempic intro pricing ($199/mo for first 2 fills) is market-leading for brand-name access
  • +Oral Wegovy pill available at $149-199/mo, one of the cheapest oral semaglutide routes
  • +Insurance accepted, GoodRx's integration with savings cards can stack with coverage

Cons

  • Model changed from pay-per-visit to subscription, users expecting à-la-carte pricing should double-check current terms
  • Compounded GLP-1s are de-emphasized on current marketing, may no longer be available
  • Subscription model means ongoing monthly fee even in maintenance months
  • Follow-up clinical care is still basic compared to dedicated GLP-1 platforms

Hers

Pros

  • +FDA-approved brand paths include Wegovy pill, Foundayo, and Ozempic pill medication from $149 and a Wegovy pen from $199; with the required membership, a $149 medication path totals $188 initially and $298/mo ongoing
  • +Zepbound access via the Lilly/Hims-Hers partnership announced 2026
  • +Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
  • +Broader women's health platform, integrates weight loss with hormonal, skin, and wellness services

Cons

  • Pending federal enforcement action against the parent company. On July 29, 2026 the FTC, joined by Utah and California acting through Los Angeles County Counsel, filed a complaint against Hims & Hers Health, Inc. in the U.S. District Court for the Northern District of California, alleging violations of the FTC Act and the Restore Online Shoppers' Confidence Act over subscription billing, cancellation friction, and sharing consumer health information with advertising platforms. Case status is Pending. These are allegations, not findings.
  • Every medication figure excludes the required Weight Loss Membership ($39 first month, then $149/mo); exact product and dose prices can increase the total above the $188/$298 floor
  • Support runs at big-platform scale, fine for routine refills, less personal if you want high-touch care
  • Compounded pricing starts at $199/mo with stepped pricing at higher doses, budget for the dose you'll end up on, not the entry dose
  • Zepbound medication starts at $299 before the required membership; that path totals $338 in month one and at least $448/mo ongoing, with exact dose pricing potentially higher

Our Verdict

Hers edges out GoodRx Care with a score of 7.3/10 vs 6.2/10. Published pricing is not a like-for-like monthly comparison: GoodRx Care is $119/mo subscription + medication; Hers is $188 first month, then $298/mo. GoodRx Care accepts insurance, which can significantly reduce your out-of-pocket costs. Hers offers both brand-name and compounded medications, giving you more flexibility.

Related comparisons

More head-to-head comparisons involving GoodRx Care and Hers.

Not comparing, just asking? Quick answers to the most-asked GLP-1 questions →

Not sure which one is right for you?

Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.